First person – Tuba Sural-Fehr
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Tuba Sural-Fehr is first author on ‘Inhibition of the IGF-1–PI3K–Akt–mTORC2 pathway i...
Format: | Article |
---|---|
Language: | English |
Published: |
The Company of Biologists
2019-05-01
|
Series: | Disease Models & Mechanisms |
Online Access: | http://dmm.biologists.org/content/12/5/dmm040402 |
id |
doaj-9b27f09b6f134d9dac0a52caaf59b190 |
---|---|
record_format |
Article |
spelling |
doaj-9b27f09b6f134d9dac0a52caaf59b1902020-11-25T02:18:19ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112019-05-0112510.1242/dmm.040402040402First person – Tuba Sural-FehrFirst Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Tuba Sural-Fehr is first author on ‘Inhibition of the IGF-1–PI3K–Akt–mTORC2 pathway in lipid rafts increases neuronal vulnerability in a genetic lysosomal glycosphingolipidosis’, published in DMM. Tuba conducted the research described in this article while a Postdoctoral Fellow in Dr Ernesto Bongarzone's lab at University of Illinois-Chicago, Chicago, USA.http://dmm.biologists.org/content/12/5/dmm040402 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
title |
First person – Tuba Sural-Fehr |
spellingShingle |
First person – Tuba Sural-Fehr Disease Models & Mechanisms |
title_short |
First person – Tuba Sural-Fehr |
title_full |
First person – Tuba Sural-Fehr |
title_fullStr |
First person – Tuba Sural-Fehr |
title_full_unstemmed |
First person – Tuba Sural-Fehr |
title_sort |
first person – tuba sural-fehr |
publisher |
The Company of Biologists |
series |
Disease Models & Mechanisms |
issn |
1754-8403 1754-8411 |
publishDate |
2019-05-01 |
description |
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Tuba Sural-Fehr is first author on ‘Inhibition of the IGF-1–PI3K–Akt–mTORC2 pathway in lipid rafts increases neuronal vulnerability in a genetic lysosomal glycosphingolipidosis’, published in DMM. Tuba conducted the research described in this article while a Postdoctoral Fellow in Dr Ernesto Bongarzone's lab at University of Illinois-Chicago, Chicago, USA. |
url |
http://dmm.biologists.org/content/12/5/dmm040402 |
_version_ |
1724882944134217728 |